India's Homegrown Covaxin To Get WHO Approval Soon

WHO is likely to take a call on emergency use listing of India's homegrown 'Covaxin' developed by Bharat Biotech in four to six weeks, Chief WHO Scientist Dr. Soumy Swaminathan said. The safety data, complete trial data, and manufacturing quality data for approval have been submitted by Bharat Biotech for review. Covaxin is now accepted in 16 countries and has shown 77.8% efficiency against symptomatic infection, as per reports.